NNMT and breast carcinoma: As shown in Table 1, the NNMTh percentage of breast cancer samples was 53.9% (89/165), which was significantly higher than that of paracancerous tissues (13.3%) and breast hyperplasia (10.0%) (p < 0.001), which indicates that NNMT expression was upregulated in breast cancer.